English
简体中文
繁體中文
English
Filipino
हिन्दी
Hmong
Bahasa Indonesia
日本語
Basa Jawa
한국어
ພາສາລາວ
Bahasa Melayu
മലയാളം
ဗမာစာ
سنڌي
தமிழ்
ไทย
Tiếng Việt
Afrikaans
Shqip
العربية
አማርኛ
Հայերեն
Azərbaycan dili
Euskara
Беларуская мова
বাংলা
Bosanski
Български
Català
Cebuano
Chichewa
Corsu
Italiano
Hrvatski
Čeština
Dansk
Nederlands
Esperanto
Eesti
Suomi
Frysk
Galego
ქართული
Ελληνικά
ગુજરાતી
Kreyol ayisyen
Deutsch
Français
Harshen Hausa
Ōlelo Hawaiʻi
עִבְרִית
Magyar
Íslenska
Igbo
Gaeilge
ಕನ್ನಡ
Қазақ тілі
ភាសាខ្មែរ
كوردی
Кыргызча
Latin
Latviešu valoda
Lietuvių kalba
Lëtzebuergesch
Македонски јазик
Malagasy
Maltese
Te Reo Māori
मराठी
Монгол
नेपाली
Norsk bokmål
پښتو
فارسی
Polski
Português
ਪੰਜਾਬੀ
Română
Русский
Samoan
Gàidhlig
Српски језик
Sesotho
Shona
සිංහල
Slovenčina
Slovenščina
Afsoomaali
Español
Basa Sunda
Kiswahili
Svenska
Тоҷикӣ
తెలుగు
Türkçe
Українська
اردو
O‘zbekcha
Cymraeg
isiXhosa
יידיש
Yorùbá
ZuluA recent publication in The International Journal of Oral & Maxillofacial Implants has highlighted the superiority of ZimVie Dental’s Puros Cancellous Particulate Allograft over other competitive freeze-dried allograft solutions in terms of physicochemical properties and ability to support bone formation.
The article compared the effects of different tissue processing methods on the properties of allografts, including Puros Cancellous Particulate Allograft, Creos™, OraGraft®, and MinerOss™.
Surface Area 100 times higher than Freeze-dried Allografts
The study showed that the surface area of Puros Cancellous Particulate Allograft was 100 times higher than that of the freeze-dried allografts, which is critical for implant dentistry, as the strength and health of grafted sites are crucial for implant success.
The study also found that the collagen microstructure and the size of individual fibers of Puros Cancellous Particulate Allograft were almost identical to those of unprocessed human bone tissue.
This resulted in a significantly higher response from a specific type of stromal cells (from bone marrow) in vitro (hBMSC).
Well-documented Clinical History
Puros Cancellous Particulate Allograft has a well-documented clinical history and is an easy-to-handle choice for predictable bone reconstruction.
It acts as an osteoconductive scaffold for new bone formation and is processed using the Tutoplast Tissue Sterilization Process, which has over 50 years of successful clinical use and zero incidents of implant-associated infections.
ZimVie Dental’s Puros portfolio is supported by over 300 peer-reviewed scientific papers, making it the gold standard in allograft bone substitutes.
About ZimVie Inc.
ZimVie Inc. is a global life sciences leader in the dental and spine markets that develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to treat a wide range of spine pathologies and support dental tooth replacement and restoration procedures.
The company was founded in March 2022 as an independent, publicly traded spin-off of the Dental and Spine business units of Zimmer Biomet.
The information and viewpoints presented in the above news piece or article do not necessarily reflect the official stance or policy of Dental Resource Asia or the DRA Journal. While we strive to ensure the accuracy of our content, Dental Resource Asia (DRA) or DRA Journal cannot guarantee the constant correctness, comprehensiveness, or timeliness of all the information contained within this website or journal.
Please be aware that all product details, product specifications, and data on this website or journal may be modified without prior notice in order to enhance reliability, functionality, design, or for other reasons.
The content contributed by our bloggers or authors represents their personal opinions and is not intended to defame or discredit any religion, ethnic group, club, organisation, company, individual, or any entity or individual.